Meridian Management CO Bristol Myers Squibb CO Transaction History
Meridian Management CO
- $355 Million
- Q2 2025
A detailed history of Meridian Management CO transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Meridian Management CO holds 14,045 shares of BMY stock, worth $645,086. This represents 0.18% of its overall portfolio holdings.
Number of Shares
14,045
Previous 14,265
1.54%
Holding current value
$645,086
Previous $870,000
25.29%
% of portfolio
0.18%
Previous 0.28%
Shares
23 transactions
Others Institutions Holding BMY
# of Institutions
2,668Shares Held
1.58BCall Options Held
26.1MPut Options Held
23.8M-
Vanguard Group Inc Valley Forge, PA195MShares$8.95 Billion0.15% of portfolio
-
Black Rock Inc. New York, NY159MShares$7.29 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY108MShares$4.96 Billion0.52% of portfolio
-
State Street Corp Boston, MA94.8MShares$4.36 Billion0.24% of portfolio
-
Capital International Investors Los Angeles, CA66.5MShares$3.05 Billion0.83% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $97.7B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...